Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark L. Jacobson currently holds 104,954 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark L. Jacobson has been a net seller of AXSM stock. They have purchased $0 and sold $16.1M worth of shares.
Mark L. Jacobson's most recent insider trade was on Sep 3, 2026, when they sold 10,000 shares at $0.00 per share.
Mark L. Jacobson serves as Executive at Axsome Therapeutics, Inc. (AXSM). They have executed 27 insider transactions totaling $16.1M over their tenure at the company.
Mark L. Jacobson holds the position of Executive at Axsome Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Mark L. Jacobson has shown a selling trading pattern, with $0 in total purchases and $16.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark L. Jacobson was on Sep 16, 2025, when they sold $4.6M worth of AXSM shares. This transaction involved 40,000 shares at $114.23 per share.
Mark L. Jacobson currently owns 104,954 shares of Axsome Therapeutics, Inc. (AXSM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark L. Jacobson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark L. Jacobson has 27 Form 4 filings on record as an insider at Axsome Therapeutics, Inc..
Set alerts for Mark L. Jacobson and 40,000+ other insiders.